Patents by Inventor Ashley Knights

Ashley Knights has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12153042
    Abstract: This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches diagnosis of a subject's exposure to an antigen based on cell-mediated immunoresponsiveness with enhanced sensitivity which is achieved by adding a non-reducing sugar during incubation of the sample with the antigen.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: November 26, 2024
    Assignee: Cellestis Limited
    Inventors: Jeff Boyle, Ashley Knights, Carmen Munian
  • Publication number: 20230289670
    Abstract: A computer system configured to effect integration of a booking system with a communication system is provided. A contact management component obtains, via a first interface, a set of contacts of the user within a communication system. A booking management component obtains a contact identifier from the set of contacts, locates, via a second interface, an existing work area booking associated with the identifier, and generates a booking suggestion for the user comprising an identifier of an available work area, available at a suggested booking time, and determined based on a timing and a location of the existing work area booking. A rendering component renders the booking suggestion in a user interface. The booking suggestion is selectable to cause a booking request to be submitted to the second interface, the booking request comprising an identifier of the user, the suggested booking time, and the identifier of the available work area.
    Type: Application
    Filed: February 7, 2023
    Publication date: September 14, 2023
    Applicant: FIL Investment Management Limited
    Inventor: Ashley Knight
  • Publication number: 20230289669
    Abstract: A computer system for communicating with a booking service is provided herein. The booking service is for managing bookable areas within a building. The system comprises at least one sensor of a user device configured to receive indoor positioning signals from an indoor positioning system of a building; and one or more processors. Localization processing is applied to the indoor positioning signals, and thereby a location of the user device within the building is computed. The computed location of the user device within the building is used to automatically identify, via communication with the booking service, a vacant bookable area within proximity to the user device. A user interface is rendered on a display of the user device, the user interface comprising a location suggestion, which is selectable to instigate, to the booking service, a booking request comprising an identifier of the vacant bookable area.
    Type: Application
    Filed: February 7, 2023
    Publication date: September 14, 2023
    Applicant: FIL Investment Management Limited
    Inventor: Ashley Knight
  • Publication number: 20200141927
    Abstract: This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches diagnosis of a subject's exposure to an antigen based on cell-mediated immunoresponsiveness with enhanced sensitivity which is achieved by adding a non-reducing sugar during incubation of the sample with the antigen.
    Type: Application
    Filed: January 3, 2020
    Publication date: May 7, 2020
    Inventors: Jeff Boyle, Ashley Knights, Carmen Munian
  • Patent number: 10564150
    Abstract: This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches diagnosis of a subject's exposure to an antigen based on cell-mediated immunoresponsiveness with enhanced sensitivity which is achieved by adding a non-reducing sugar during incubation of the sample with the antigen.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: February 18, 2020
    Assignee: Cellestis Limited
    Inventors: Jeff Boyle, Ashley Knights, Carmen Munian
  • Publication number: 20150330972
    Abstract: This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches diagnosis of a subject's exposure to an antigen based on cell-mediated immunoresponsiveness with enhanced sensitivity which is achieved by adding a non-reducing sugar during incubation of the sample with the antigen.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 19, 2015
    Inventors: Jeff Boyle, Ashley Knights, Carmen Munian